Prognosis
Psychedelic Companies Hope At-Home DNA Tests Bring Better Highs
An emerging industry aims to help people pick the best drug for their ailments—and the right dose.
This article is for subscribers only.
Spit into a tube and pop it in the mail, and the lab results may lead to a better high—or at least a safer one. That’s the premise of a home saliva testing kit sold for $199 by Endocanna Health Inc., which looks for 57 genetic traits that could influence a customer’s response to marijuana, so they can select the best strain and correct dose. The company also plans to look at similar factors for a range of psychotropic drugs.
“Your DNA is your blueprint,” says Len May, chief executive officer of the Burbank, Calif.-based startup. “It gives you a GPS that can guide you to an experience that is more optimal and helps you avoid sharp corners.”